Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Terminology Article
This is a selection made from among articles on Drug Treatment Terminology. For a permanent link to this article, or to bookmark it for future reading, click here.
from:
Alcohol and Drug Rehab Treatment: Critical Decisions
By David Westbrook
Choosing the right alcohol or drug rehab center can make all the difference when it comes to entering long-term recovery from an addiction. The task of finding the “right” drug rehab center is complicated by the fact that there are over 13,000 drug rehab facilities around the country. Each of these treatment centers is unique, but being unique does not necessarily mean that they are all equally good. It does, however, mean that you have many drug rehab centers to choose from and if you do not find the right one immediately you should continue searching as there are many high quality centers.
Here are ten questions to help you in your search for the right drug or alcohol rehab facility.
1. How does the treatment center define success and what is their success rate?
Many drug treatment facilities will have had independent reviews of their success. However, success can be measured in many ways. One treatment center may say they have a 74% success rate, but only be considering clients who remain sober for 6 months; another center may claim a 68% rate based on the results of clients after one year. Whatever their claimed success rate you will want to know how they measured it and what they consider success.
2. Are they accredited as a drug rehab center? And if so by whom?
There are a handful of national accreditation organizations including Joint Commission On Accreditation Of Healthcare Organizations (JACHO) and Commission on Accreditation of Rehabilitation Facilities (CARF), among others. Organizations accredited by these bodies frequently have undergone site reviews and have measured up to national standards.
3. What are the credentials of their staff?
Most states have a system for credentialing drug and alcohol counselors. These individuals may be Certified Addictions Counselors (CAC) or Certified Alcohol and Drug Counselors (CADC). These are minimum certifications, lead counselors should hold be MSW or LCSW level or higher.
4. Do they provide medically supervised withdrawal?
With some drugs proper withdrawal supervision can be a matter of life or death. If the treatment center does not have a detox center can they recommend one for attendance prior to treatment.
5. What does a typical week in their drug rehab facility look like?
There should be a balance of group and individual therapy. Education sessions, opportunities for reflection and support groups along with other components.
6. Can the provide testimonials?
True, no treatment center would put on display their failures, but they should be able to tell you about their successes.
7. How do they assist in setting up aftercare?
Aftercare has been found to be crucial to the success of long-term recovery. A good treatment center should either offer aftercare of be able to assist you in locating aftercare in your community.
8. Do they have a diverse group of counselors, and how will you be matched up?
One of the primary determinants of treatment success is a good client-counselor relationship. Therefore, a match between counselor and client should be worked towards.
9. What is their treatment modality or philosophy?
Find out if they are 12-step oriented, use motivational, cognitive or behavioral therapies, and then ask them to explain any terms you might not understand.
10. Do they work with your insurance company or can they set-up a payment plan?
Make sure you ask if they can work with your insurance company, or if your insurance does not pay for treatment work out how payment is to be handled.
Use a systematic program for identifying treatment centers which may be right for you. You may wish to print these questions out and keep a separate worksheet for each center’s answers. Remember, the right drug rehab center is waiting for you to call today.
© 2005, David Westbrook
About the Author: David Westbrook is a freelance writer and the creator of www.addictionsresources.com and www.alcoholismresrouces.com
© 2005, David Westbrook
About the Author: David Westbrook is a freelance writer and the creator of http://www.addictionsresources.com and http://www.alcoholismresources.com
Article Source: http://EzineArticles.com/?expert=David_Westbrook
http://EzineArticles.com/?Alcohol-and-Drug-Rehab-Treatment:-Critical-Decisions&id=18760
Drug Treatment Terminology Specific links
Drug Treatment Terminology News
Novartis Drug Afinitor® Approved By FDA As First Medication To Treat Patients With Non-Cancerous Kidney Tumors ...
Novartis Pharmaceuticals Corporation ("Novartis") announced today that the US Food and Drug Administration (FDA) approved Afinitor® (everolimus) tablets* for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery(2).
Read more...ChemoCentryx Presents Data on CCX168, an Orally Administered Small Molecule Inhibitor of C5aR, at the 49th European ...
MOUNTAIN VIEW, Calif. -- ChemoCentryx, Inc. , today announced the presentation of results from the Company's development program for CCX168, an investigational orally administered inhibitor of the complement ...
Read more...Alliqua Names Dr. Michael Moore to Its Scientific Advisory Board
NEW YORK -- Alliqua, Inc. ("Alliqua" or the "Company"), an advanced biomedical products company focused on the development and manufacturing of proprietary drug delivery and liver health ...
Read more...Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg Capsules
ALLEGAN, Mich., May 18, 2012 /PRNewswire/ --Â Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug ...
Read more...Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
ALLEGAN, Mich., May 22, 2012 /PRNewswire/ --Â Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug ...
Read more...Orchestrating drug management (American College of Physicians annual scientific meeting)
Managing medications is becoming more complicated due to the aging population, use of opioids for chronic pain and increased FDA drug safety messages.
Read more...Medgenics Receives FDA Clearance to Commence Phase IIb Trial of EPODURE for Sustained Anemia Treatment in Dialysis ...
Medgenics, Inc. , developer of the novel Biopump™ technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the U.S.
Read more...New data among 200 Lucentis® abstracts at ARVO show low number of injections with Novartis drug required to achieve ...
Data from key studies highlight the value of individualized therapy and reinforce Lucentis (ranibizumab) well-characterized long-term efficacy and safety profile RESTORE extension study in DME patients ...
Read more...Medgenics Inc - FDA Clearance for Phase IIb Trial of EPODURE
 Press Release 17 May 2012 Medgenics Receives FDA Clearance to Commence Phase IIb Trial of EPODURE for Sustained Anemia Treatment in Dialysis Patients First U.S. Study with Company's Biopump Platform ...
Read more...Bestellen Sie den kostenlosen Newsletter von 4investors:
Novartis International AG / Novartis drug pasireotide LAR shows superior efficacy compared to Sandostatin® LAR® in Phase III trial of patients with acromegaly . Processed and transmitted by Thomson Reuters ONE.
Read more...